Founder Joe Kiani has led Masimo for 35 years. But he says he'll quit if he loses this week's proxy vote to Politan Capital.

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than ...

The Apple Watch Series 10 lacks blood oxygen readings due to an ongoing legal dispute with patent holder Masimo. It's ...

ECG leads were placed on the infant's chest. Masimo and Nellcor oximeter sensors were randomly allocated to each foot. Measurements were collected for 10mins. Screens from the oximeters and ECG ...

Masimo is partnering with Qualcomm Technologies to develop a comprehensive reference platform to expand the Wear OS by Google™ ecosystem.

Masimo announced a partnership with Google to develop a comprehensive smartwatch reference platform for OEMs building Wear OS ...

Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in ...

Masimo Corporation MASI recently announced ... based on data from an unobtrusive pulse oximeter worn on the patient’s wrist, especially in situations where there are logistical difficulties ...

Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters ® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless ...

A peer-reviewed publication using appropriately standardized sensor application sites demonstrated that Masimo RD SET sensors had only ... which is not clinically significant because pulse oximeters ...

The September 19, 2024 Annual Meeting is fast approaching, and it’s important to vote as soon as possible. The Company urges stockholders to vote “FOR” Masimo’s director nominees, Joe Kiani and ...